Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 129 articles:
HTML format
Text format



Single Articles


    June 2018
  1. RUSSO R, Bozzola E, Villani A
    Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society.
    Vaccine. 2018 Jun 4. pii: S0264-410X(18)30794.
    PubMed     Text format    


    May 2018
  2. LIU X, Yang C, Zhong Q, Song Q, et al
    Improved timely birth dose coverage of hepatitis B vaccine narrows the socio-economic inequality in western China in 2011-2016.
    Vaccine. 2018 May 26. pii: S0264-410X(18)30751.
    PubMed     Text format     Abstract available


  3. CHUAI X, Xie B, Chen H, Tan X, et al
    The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
    Vaccine. 2018 May 16. pii: S0264-410X(18)30681.
    PubMed     Text format     Abstract available


  4. CHEAH BC, Davies J, Singh GR, Wood N, et al
    Sub-optimal protection against past hepatitis B virus infection where subtype mismatch exists between vaccine and circulating viral genotype in northern Australia.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30122.
    PubMed     Text format     Abstract available


  5. BREDBERG A, Boe OW, Bredberg J, Whist JE, et al
    Detection of hepatitis B surface antigen in blood following vaccination.
    Vaccine. 2018 May 4. pii: S0264-410X(18)30600.
    PubMed     Text format    


    April 2018
  6. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
    Hepatitis B vaccination coverage among adults aged >/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
    Vaccine. 2018 Apr 28. pii: S0264-410X(18)30376.
    PubMed     Text format     Abstract available


  7. REEKIE J, Kaldor JM, Mak DB, Ward J, et al
    Long-term impact of childhood hepatitis B vaccination programs on prevalence among Aboriginal and non-Aboriginal women giving birth in Western Australia.
    Vaccine. 2018 Apr 26. pii: S0264-410X(18)30554.
    PubMed     Text format     Abstract available


  8. LINK-GELLES R, Hofmeister MG, Nelson NP
    Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40years of age: A systematic review of published studies and recommendations for vaccine use.
    Vaccine. 2018 Apr 16. pii: S0264-410X(18)30484.
    PubMed     Text format     Abstract available


  9. TAVOSCHI L, Severi E, Carrillo Santisteve P, Lopalco P, et al
    Hepatitis A in the EU/EEA: The case for scaling up prevention.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30299.
    PubMed     Text format    


  10. HYER R, McGuire DK, Xing B, Jackson S, et al
    Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults.
    Vaccine. 2018 Apr 5. pii: S0264-410X(18)30436.
    PubMed     Text format     Abstract available


    March 2018
  11. GARCIA D, Porras A, Rico Mendoza A, Alvis N, et al
    Hepatitis B infection control in Colombian Amazon after 15years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
    Vaccine. 2018 Mar 30. pii: S0264-410X(17)31546.
    PubMed     Text format     Abstract available


  12. LU PJ, O'Halloran AC, Williams WW, Nelson NP, et al
    Hepatitis B vaccination coverage among adults aged>/=18years traveling to a country of high or intermediate endemicity, United States, 2015.
    Vaccine. 2018 Mar 28. pii: S0264-410X(18)30375.
    PubMed     Text format     Abstract available


  13. LI X, Xu Y, Dong Y, Yang X, et al
    Monitoring the efficacy of infant hepatitis B vaccination and revaccination in 0- to 8-year-old children: Protective anti-HBs levels and cellular immune responses.
    Vaccine. 2018 Mar 24. pii: S0264-410X(18)30389.
    PubMed     Text format     Abstract available


  14. WEI S, Lei Y, Yang J, Wang X, et al
    Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Vaccine. 2018 Mar 22. pii: S0264-410X(18)30381.
    PubMed     Text format     Abstract available


  15. KLINGER G, Chodick G, Levy I
    Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis.
    Vaccine. 2018 Mar 21. pii: S0264-410X(18)30373.
    PubMed     Text format     Abstract available


  16. LIU Y, Ma C, Jia H, Xu E, et al
    Knowledge, attitudes, and practices regarding hepatitis B vaccination among hospital-based doctors and nurses in China: Results of a multi-site survey.
    Vaccine. 2018 Mar 19. pii: S0264-410X(18)30354.
    PubMed     Text format     Abstract available


  17. ZHANG L, Yan B, Lv J, Liu J, et al
    Antibody response to hepatitis B vaccine is independently associated with hepatitis B breakthrough infection among adults: Results from a three-year follow-up study in China.
    Vaccine. 2018 Mar 13. pii: S0264-410X(18)30213.
    PubMed     Text format     Abstract available


  18. ZHENG M, Jiang J, Zhang X, Wang N, et al
    Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
    Vaccine. 2018 Mar 12. pii: S0264-410X(18)30341.
    PubMed     Text format     Abstract available


    February 2018
  19. YUE X, Black CL, O'Halloran A, Lu PJ, et al
    Hepatitis A and hepatitis B vaccination coverage among adults with chronic liver disease.
    Vaccine. 2018;36:1183-1189.
    PubMed     Text format     Abstract available


  20. WANG D, Zhang Y, Ma C, Ma D, et al
    Live recombinant Lactococcuslactis expressing avian hepatitis virus ORF2 protein: Immunoprotection against homologous virus challenge in chickens.
    Vaccine. 2018;36:1108-1115.
    PubMed     Text format     Abstract available


  21. MOUCHET J, Salvo F, Raschi E, Poluzzi E, et al
    Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30210.
    PubMed     Text format     Abstract available


  22. FREIDL GS, Tostmann A, Curvers M, Ruijs WLM, et al
    Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.
    Vaccine. 2018 Feb 14. pii: S0264-410X(18)30152.
    PubMed     Text format     Abstract available


  23. KOURKOUNTI S, Retsas T, Paparizos V, Tsimpidakis A, et al
    Evaluation of a convenient vaccination schedule against hepatitis B in HIV-patients with undetectable HIV viral load.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30192.
    PubMed     Text format     Abstract available


  24. NELSON NP, Yankey D, Singleton JA, Elam-Evans LD, et al
    Hepatitis A vaccination coverage among adolescents (13-17years) in the United States, 2008-2016.
    Vaccine. 2018 Feb 12. pii: S0264-410X(18)30163.
    PubMed     Text format     Abstract available


  25. SUN X, Wang F, Zheng H, Miao N, et al
    The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
    Vaccine. 2018 Feb 1. pii: S0264-410X(18)30092.
    PubMed     Text format     Abstract available


    January 2018
  26. OMENACA F, Vazquez L, Garcia-Corbeira P, Mesaros N, et al
    Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity.
    Vaccine. 2018 Jan 11. pii: S0264-410X(18)30029.
    PubMed     Text format     Abstract available


  27. RAMIREZ A, Morris S, Maucourant S, D'Ascanio I, et al
    A virus-like particle vaccine candidate for influenza A virus based on multiple conserved antigens presented on hepatitis B tandem core particles.
    Vaccine. 2018 Jan 3. pii: S0264-410X(17)31814.
    PubMed     Text format     Abstract available


    December 2017
  28. GUPTA A, Popowich S, Ojkic D, Kurukulasuriya S, et al
    Inactivated and live bivalent fowl adenovirus (FAdV8b+FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH).
    Vaccine. 2017 Dec 29. pii: S0264-410X(17)31808.
    PubMed     Text format     Abstract available


  29. JACKSON S, Lentino J, Kopp J, Murray L, et al
    Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults.
    Vaccine. 2017 Dec 27. pii: S0264-410X(17)31791.
    PubMed     Text format     Abstract available


  30. SHIVE CL, Judge CJ, Clagett B, Kalayjian RC, et al
    Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection.
    Vaccine. 2017 Dec 15. pii: S0264-410X(17)31761.
    PubMed     Text format     Abstract available


  31. HABER P, Moro PL, Ng C, Lewis PW, et al
    Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Vaccine. 2017 Dec 11. pii: S0264-410X(17)31722.
    PubMed     Text format     Abstract available


  32. VON DELFT A, Donnison TA, Lourenco J, Hutchings C, et al
    The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.
    Vaccine. 2017 Dec 1. pii: S0264-410X(17)31487.
    PubMed     Text format     Abstract available


    November 2017
  33. WEI KP, Zhu FC, Liu JX, Yan L, et al
    The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study.
    Vaccine. 2017 Nov 28. pii: S0264-410X(17)31601.
    PubMed     Text format     Abstract available


  34. CHEN Y, Zhou CL, Zhang XJ, Hao ZY, et al
    Immune memory at 17-years of follow-up of a single dose of live attenuated hepatitis A vaccine.
    Vaccine. 2017 Nov 25. pii: S0264-410X(17)31600.
    PubMed     Text format     Abstract available


  35. MORO PL, Zheteyeva Y, Barash F, Lewis P, et al
    Assessing the safety of hepatitis B vaccination during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 1990-2016.
    Vaccine. 2017 Nov 23. pii: S0264-410X(17)31603.
    PubMed     Text format     Abstract available


  36. CHILDS L, Roesel S, Tohme RA
    Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.
    Vaccine. 2017 Nov 21. pii: S0264-410X(17)31591.
    PubMed     Text format     Abstract available


  37. PETIT D, Tevi-Benissan C, Woodring J, Hennessey K, et al
    Countries' interest in a hepatitis B vaccine licensed for the controlled temperature chain; survey results from African and Western Pacific regions.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31421.
    PubMed     Text format     Abstract available


  38. HUO C, Yang J, Lei L, Qiao L, et al
    Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice.
    Vaccine. 2017 Nov 9. pii: S0264-410X(17)31530.
    PubMed     Text format     Abstract available


    October 2017
  39. LANDI A, Law J, Hockman D, Logan M, et al
    Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes.
    Vaccine. 2017 Oct 28. pii: S0264-410X(17)31480.
    PubMed     Text format     Abstract available


  40. LU Y, Zhu FC, Liu JX, Zhai XJ, et al
    The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China.
    Vaccine. 2017 Oct 24. pii: S0264-410X(17)31428.
    PubMed     Text format     Abstract available


  41. WANG J, Qiu J, Zhu Y, Zhou H, et al
    Molecular evolution of hepatitis B vaccine escape variants in China, during 2000-2016.
    Vaccine. 2017;35:5808-5813.
    PubMed     Text format     Abstract available


  42. FUKUSHIMA S, Kiyohara T, Ishii K, Nakano T, et al
    Immunogenicity of aluminum-adsorbed hepatitis A vaccine (Havrix(R)) administered as a third dose after primary doses of Japanese aluminum-free hepatitis A vaccine (Aimmugen(R)) for Japanese travelers to endemic countries.
    Vaccine. 2017 Oct 10. pii: S0264-410X(17)31357.
    PubMed     Text format     Abstract available


  43. PILEGGI C, Papadopoli R, Bianco A, Pavia M, et al
    Hepatitis B vaccine and the need for a booster dose after primary vaccination.
    Vaccine. 2017 Oct 5. pii: S0264-410X(17)31329.
    PubMed     Text format     Abstract available


    September 2017
  44. BOHM K, Filomena A, Schneiderhan-Marra N, Krause G, et al
    Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.
    Vaccine. 2017 Sep 14. pii: S0264-410X(17)31189.
    PubMed     Text format     Abstract available


  45. OKADA Y, Uno N, Sato S, Mori S, et al
    Strong influence of human leukocyte antigen-DP variants on response to hepatitis B vaccine in a Japanese population.
    Vaccine. 2017 Sep 4. pii: S0264-410X(17)31133.
    PubMed     Text format     Abstract available


    August 2017
  46. JAYASUNDARA D, Hui BB, Regan DG, Heywood AE, et al
    Quantifying the population effects of vaccination and migration on hepatitis A seroepidemiology in Australia.
    Vaccine. 2017 Aug 17. pii: S0264-410X(17)31089.
    PubMed     Text format     Abstract available


  47. CAO YF, Tao H, Hu YM, Shi CB, et al
    A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine.
    Vaccine. 2017 Aug 10. pii: S0264-410X(17)30731.
    PubMed     Text format     Abstract available


  48. SCHLAUD M, Schmitz R, Poethko-Muller C, Kuhnert R, et al
    Vaccinations in the first year of life and risk of atopic disease - Results from the KiGGS study.
    Vaccine. 2017 Aug 8. pii: S0264-410X(17)31062.
    PubMed     Text format     Abstract available


  49. CADAVID-BETANCUR DA, Ospina MC, Hincapie-Palacio D, Bernal-Restrepo LM, et al
    Seroprevalence of hepatitis B and factors potentially associated in a population-based study in Medellin, Colombia.
    Vaccine. 2017 Aug 3. pii: S0264-410X(17)31010.
    PubMed     Text format     Abstract available


    July 2017
  50. HE H, Zhou Y, Xie S
    Assessment of the duplicate notifiable reporting of hepatitis B infection in Zhejiang province, China, 2005-2015.
    Vaccine. 2017 Jul 24. pii: S0264-410X(17)30947.
    PubMed     Text format     Abstract available


  51. WORLD HEALTH ORGANIZATION
    Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations.
    Vaccine. 2017 Jul 22. pii: S0264-410X(17)30954.
    PubMed     Text format     Abstract available


  52. PATEL DP, Treat JR, Castelo-Socio L
    Decreased Hepatitis B vaccine response in pediatric patients with atopic dermatitis, psoriasis, and morphea.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30933.
    PubMed     Text format     Abstract available


  53. HUYNH C, Minuk GY, Uhanova J, Baikie M, et al
    Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Vaccine. 2017 Jul 20. pii: S0264-410X(17)30948.
    PubMed     Text format     Abstract available


  54. LI X, Heffelfinger J, Wiesen E, Diorditsa S, et al
    Improving hepatitis B birth dose coverage through village health volunteer training and pregnant women education.
    Vaccine. 2017 Jul 5. pii: S0264-410X(17)30853.
    PubMed     Text format     Abstract available


  55. ZHOU Y, He H, Deng X, Yan R, et al
    Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
    Vaccine. 2017 Jul 4. pii: S0264-410X(17)30875.
    PubMed     Text format     Abstract available


    June 2017
  56. LARA AN, Sartori AM, Fonseca MO, Lopes MH, et al
    Long-term protection after hepatitis B vaccination in people living with HIV.
    Vaccine. 2017 Jun 29. pii: S0264-410X(17)30827.
    PubMed     Text format     Abstract available


  57. ALLISON RD, Patel MK, Tohme RA
    Hepatitis B vaccine birth dose coverage correlates worldwide with rates of institutional deliveries and skilled attendance at birth.
    Vaccine. 2017 Jun 28. pii: S0264-410X(17)30848.
    PubMed     Text format     Abstract available


  58. WANG F, Zhang G, Zheng H, Miao N, et al
    Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Vaccine. 2017 Jun 23. pii: S0264-410X(17)30796.
    PubMed     Text format     Abstract available


  59. ZANETTI A, Desole MG, Romano L, d'Alessandro A, et al
    Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.
    Vaccine. 2017 Jun 14. pii: S0264-410X(17)30683.
    PubMed     Text format     Abstract available


  60. RAMIREZ-SOTO MC, Ortega-Caceres G, Cabezas C
    Trends in mortality burden of hepatocellular carcinoma, cirrhosis, and fulminant hepatitis before and after roll-out of the first pilot vaccination program against hepatitis B in Peru: An analysis of death certificate data.
    Vaccine. 2017 Jun 8. pii: S0264-410X(17)30756.
    PubMed     Text format     Abstract available


  61. CHEN MS JR, Dang JH
    What might we learn from the more successful uptake of Hepatitis B (HBV) vaccinations to increase Human Papillomavirus (HPV) vaccinations in adolescents?
    Vaccine. 2017 Jun 8. pii: S0264-410X(17)30746.
    PubMed     Text format    


  62. MARTINON-TORRES F, Boisnard F, Thomas S, Sadorge C, et al
    Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
    Vaccine. 2017 Jun 2. pii: S0264-410X(17)30679.
    PubMed     Text format     Abstract available


    May 2017
  63. SYED SF, Sun Y, Du T, Chen Y, et al
    Evaluation of recombinant Chinese avian hepatitis E virus (CaHEV) ORF2 and ORF3 proteins for protection of chickens against CaHEV infection.
    Vaccine. 2017 May 18. pii: S0264-410X(17)30638.
    PubMed     Text format     Abstract available


  64. DENG Y, Chuai X, Chen P, Chen H, et al
    Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.
    Vaccine. 2017 May 6. pii: S0264-410X(17)30551.
    PubMed     Text format     Abstract available


  65. MANGEN MJ, Stibbe H, Urbanus A, Siedenburg EC, et al
    Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Vaccine. 2017 May 5. pii: S0264-410X(17)30560.
    PubMed     Text format     Abstract available


  66. WONG CKH, Liao Q, Guo VYW, Xin Y, et al
    Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
    Vaccine. 2017 May 2. pii: S0264-410X(17)30542.
    PubMed     Text format     Abstract available


    April 2017
  67. WICHGERS SCHREUR PJ, van Keulen L, Kant J, Kortekaas J, et al
    Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30498.
    PubMed     Text format     Abstract available


  68. LU PJ, O'Halloran A, Kennedy ED, Williams WW, et al
    Awareness among adults of vaccine-preventable diseases and recommended vaccinations, United States, 2015.
    Vaccine. 2017 Apr 27. pii: S0264-410X(17)30503.
    PubMed     Text format     Abstract available


  69. SIL A, Ravi MD, Patnaik BN, Dhingra MS, et al
    Effect of prophylactic or therapeutic administration of paracetamol on immune response to DTwP-HepB-Hib combination vaccine in Indian infants.
    Vaccine. 2017 Apr 24. pii: S0264-410X(17)30315.
    PubMed     Text format     Abstract available


  70. SEREMBA E, Van Geertruyden JP, Ssenyonga R, Opio CK, et al
    Early childhood transmission of hepatitis B prior to the first hepatitis B vaccine dose is rare among babies born to HIV-infected and non-HIV infected mothers in Gulu, Uganda.
    Vaccine. 2017 Apr 20. pii: S0264-410X(17)30484.
    PubMed     Text format     Abstract available


  71. BREAKWELL L, Anga J, Dadari I, Sadr-Azodi N, et al
    Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.
    Vaccine. 2017 Apr 18. pii: S0264-410X(17)30473.
    PubMed     Text format     Abstract available


  72. JIANG HY, Wang SY, Deng M, Li YC, et al
    Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: A systematic review and meta-analysis.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30432.
    PubMed     Text format     Abstract available


    March 2017
  73. LOBAINA Y, Michel ML
    Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30366.
    PubMed     Text format     Abstract available


  74. SHI J, Feng Y, Gao L, Feng D, et al
    Immunogenicity and safety of a high-dose hepatitis B vaccine among patients receiving methadone maintenance treatment: A randomized, double-blinded, parallel-controlled trial.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30340.
    PubMed     Text format     Abstract available


  75. XU B, Zhu D, Bi Y, Wang Y, et al
    Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30327.
    PubMed     Text format     Abstract available


    February 2017
  76. CHAPPUIS F, Farinelli T, Deckx H, Sarnecki M, et al
    Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30080.
    PubMed     Text format     Abstract available


    January 2017
  77. ABARA WE, Collier MG, Teshale EH
    Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30039.
    PubMed     Text format     Abstract available


  78. KARVONEN T, Auranen K, Kuusi M, Leino T, et al
    Epidemiology of hepatitis B infection in Finland: Implications for immunisation policy.
    Vaccine. 2017;35:412-418.
    PubMed     Text format     Abstract available


  79. WANG Y, Chen T, Lu LL, Wang M, et al
    Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31296.
    PubMed     Text format     Abstract available


    December 2016
  80. ZITT E, Hafner-Giessauf H, Wimmer B, Herr A, et al
    Response to active hepatitis B vaccination and mortality in incident dialysis patients.
    Vaccine. 2016 Dec 31. pii: S0264-410X(16)31257.
    PubMed     Text format     Abstract available


  81. SAKAI A, Noguchi E, Fukushima T, Tagawa M, et al
    Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)30764.
    PubMed     Text format     Abstract available


  82. KANG W, Li Q, Shen L, Zhang L, et al
    Risk factors related to the failure of prevention of hepatitis B virus Mother-to-Child transmission in Yunnan, China.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31223.
    PubMed     Text format     Abstract available


  83. RISSMANN M, Ulrich R, Schroder C, Hammerschmidt B, et al
    Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Vaccine. 2016 Dec 21. pii: S0264-410X(16)31197.
    PubMed     Text format     Abstract available


    November 2016
  84. ALANKO BLOME M, Bjorkman P, Flamholc L, Jacobsson H, et al
    Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31102.
    PubMed     Text format     Abstract available


  85. LU Y, Liang XF, Wang FZ, Yan L, et al
    Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31123.
    PubMed     Text format     Abstract available


  86. KULKARNI SP, Thanapati S, Arankalle VA, Tripathy AS, et al
    Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate.
    Vaccine. 2016;34:5895-5902.
    PubMed     Text format     Abstract available


  87. THOMPSON C, Dey A, Fearnley E, Polkinghorne B, et al
    Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31021.
    PubMed     Text format     Abstract available


  88. LIN X, Yang J, Lu H, Zhou Y, et al
    Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31069.
    PubMed     Text format     Abstract available


  89. YU HT, Wang JY, Tian D, Wang MX, et al
    Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice.
    Vaccine. 2016 Nov 11. pii: S0264-410X(16)30998.
    PubMed     Text format     Abstract available


    October 2016
  90. ZHANG X, Wei M, Sun G, Wang X, et al
    Real-time stability of a hepatitis E vaccine (Hecolin(R)) demonstrated with potency assays and multifaceted physicochemical methods.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30980.
    PubMed     Text format     Abstract available


  91. XEUATVONGSA A, Datta SS, Moturi E, Wannemuehler K, et al
    Improving hepatitis B birth dose in rural Lao People's Democratic Republic through the use of mobile phones to facilitate communication.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30883.
    PubMed     Text format     Abstract available


    August 2016
  92. FAN W, Chen XF, Shen C, Guo ZR, et al
    Hepatitis B vaccine response in obesity: A meta-analysis.
    Vaccine. 2016 Aug 18. pii: S0264-410X(16)30699.
    PubMed     Text format     Abstract available


    July 2016
  93. PATEL MK, Wannemuehler K, Tairi R, Tutai R, et al
    Progress towards achieving hepatitis B control in the Cook Islands, Niue, Tokelau, and Kiribati.
    Vaccine. 2016 Jul 8. pii: S0264-410X(16)30563.
    PubMed     Text format     Abstract available


    June 2016
  94. ZHANG L, Yan B, Xu A
    A hepatitis E outbreak by genotype 4 virus in Shandong province, China.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30409.
    PubMed     Text format     Abstract available


  95. HANKIN-WEI A, Rein DB, Hernandez-Romieu A, Kennedy MJ, et al
    Cost-effectiveness analysis of catch-up hepatitis a vaccination among unvaccinated/partially-vaccinated children.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30464.
    PubMed     Text format     Abstract available


  96. SONDLANE TH, Mawela L, Razwiedani LL, Selabe SG, et al
    High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30366.
    PubMed     Text format     Abstract available


    May 2016
  97. DINDA AK, Bhat M, Srivastava S, Kottarath SK, et al
    Novel nanocarrier for oral Hepatitis B vaccine.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30258.
    PubMed     Text format     Abstract available


    April 2016
  98. ZHU FC, Sun KX, Pan HX, Yang ZH, et al
    The immunogenicity in healthy infants and efficiency to prevent mother to child transmission of Hepatitis B virus of a 10mug recombinant yeast-derived Hepatitis B vaccine (Hep-KSC).
    Vaccine. 2016 Apr 23. pii: S0264-410X(16)30196.
    PubMed     Text format     Abstract available


  99. LEVANDER S, Sallberg M, Ahlen G, Frelin L, et al
    A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
    Vaccine. 2016 Apr 21. pii: S0264-410X(16)30171.
    PubMed     Text format     Abstract available


  100. SADOH AE, Nwaneri DU, Ogboghodo BC, Sadoh WE, et al
    Effect of introduction of pentavalent vaccine as replacement for Diphtheria-Tetanus-Pertussis and Hepatitis B vaccines on vaccination uptake in a health facility in Nigeria.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30164.
    PubMed     Text format     Abstract available


  101. BERAN J, Van Der Meeren O, Leyssen M, D'silva P, et al
    Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30174.
    PubMed     Text format     Abstract available


  102. VAN DER MEEREN O, Behre U, Crasta P
    Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine.
    Vaccine. 2016 Apr 16. pii: S0264-410X(16)30142.
    PubMed     Text format     Abstract available


  103. ROH EY, Yoon JH, In JW, Lee N, et al
    Association of HLA-DP variants with the responsiveness to Hepatitis B virus vaccination in Korean Infants.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30087.
    PubMed     Text format     Abstract available


  104. ALLISON RD, Teleb N, Al Awaidy S, Ashmony H, et al
    Hepatitis B control among children in the Eastern Mediterranean Region of the World Health Organization.
    Vaccine. 2016 Apr 2. pii: S0264-410X(16)30059.
    PubMed     Text format     Abstract available


    March 2016
  105. KOLWAITE AR, Xeuatvongsa A, Ramirez-Gonzalez A, Wannemuehle K, et al
    Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR.
    Vaccine. 2016 Mar 31. pii: S0264-410X(16)30077.
    PubMed     Text format     Abstract available


  106. WIESEN E, Diorditsa S, Li X
    Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30056.
    PubMed     Text format     Abstract available


  107. DULAL P, Wright D, Ashfield R, Hill AV, et al
    Potency of a thermostabilised chimpanzee adenovirus Rift Valley fever vaccine in cattle.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30057.
    PubMed     Text format     Abstract available


  108. FEIRING B, Laake I, Molden T, Haberg SE, et al
    Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00255.
    PubMed     Text format     Abstract available


  109. FUSTER F, Vargas JI, Jensen D, Sarmiento V, et al
    CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.
    Vaccine. 2016 Mar 2. pii: S0264-410X(16)00236.
    PubMed     Text format     Abstract available


    February 2016
  110. SALAMA II, Sami SM, Salama SI, Rabah TM, et al
    Immune response to second vaccination series of hepatitis B virus among booster dose non-responders.
    Vaccine. 2016 Feb 27. pii: S0264-410X(16)00231.
    PubMed     Text format     Abstract available


  111. KUMAR M, Upadhyay A, Singh J, Chhabra M, et al
    Effect of change in sequence of administration of DTwP and Hepatitis B vaccines on perception of pain in infants: A randomized control trial.
    Vaccine. 2016 Feb 19. pii: S0264-410X(16)00173.
    PubMed     Text format     Abstract available


    January 2016
  112. WANG ZZ, Li MQ, Wang P, Yang ZX, et al
    Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China.
    Vaccine. 2016 Jan 19. pii: S0264-410X(16)00044.
    PubMed     Text format     Abstract available


  113. XIA M, Wei C, Wang L, Cao D, et al
    A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.
    Vaccine. 2016 Jan 9. pii: S0264-410X(16)00017.
    PubMed     Text format     Abstract available


  114. BACKES S, Jager C, Dembek CJ, Kosinska AD, et al
    Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.
    Vaccine. 2016 Jan 6. pii: S0264-410X(15)01871.
    PubMed     Text format     Abstract available


    December 2015
  115. DOEDEE AM, Kannegieter N, Ozturk K, van Loveren H, et al
    Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01799.
    PubMed     Text format     Abstract available


  116. HUMMEL IB, Zitzmann A, Erl M, Wenzel JJ, et al
    Characteristics of immune memory 10-15 years after primary hepatitis B vaccination.
    Vaccine. 2015 Dec 21. pii: S0264-410X(15)01824.
    PubMed     Text format     Abstract available


  117. PITTMAN PR, McClain D, Quinn X, Coonan KM, et al
    Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.
    Vaccine. 2015 Dec 21. pii: S0264-410X(15)01821.
    PubMed     Text format     Abstract available


  118. PITTMAN PR, Norris SL, Brown ES, Ranadive MV, et al
    Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
    Vaccine. 2015 Dec 16. pii: S0264-410X(15)01775.
    PubMed     Text format     Abstract available


  119. KUMAR A, Das S, Mullick R, Lahiri P, et al
    Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01727.
    PubMed     Text format     Abstract available


  120. JING M, Wang J, Zhu S, Ao F, et al
    Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01750.
    PubMed     Text format     Abstract available


  121. CHONWATTANA W, Raengsakulrach B, Holtz TH, Wasinrapee P, et al
    Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
    Vaccine. 2015 Dec 9. pii: S0264-410X(15)01765.
    PubMed     Text format     Abstract available


  122. VAN EFFELTERRE T, Marano C, Jacobsen KH
    Modeling the hepatitis A epidemiological transition in Thailand.
    Vaccine. 2015 Dec 1. pii: S0264-410X(15)01702.
    PubMed     Text format     Abstract available


    November 2015
  123. WIESEN E, Lagani W, Sui G, Arava J, et al
    Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014.
    Vaccine. 2015 Nov 24. pii: S0264-410X(15)01686.
    PubMed     Text format     Abstract available


  124. SU FH, Huang YL, Sung FC, Su CT, et al
    Annual influenza vaccination reduces total hospitalization in patients with chronic hepatitis B virus infection: A population-based analysis.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01585.
    PubMed     Text format     Abstract available


    August 2015
  125. MANSFIELD KL, Banyard AC, McElhinney L, Johnson N, et al
    Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.
    Vaccine. 2015 Aug 18. pii: S0264-410X(15)01134.
    PubMed     Text format     Abstract available


    June 2015
  126. HAYDEN CA, Fischer ME, Andrews BL, Chilton HC, et al
    Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.
    Vaccine. 2015;33:2881-6.
    PubMed     Text format     Abstract available


    May 2015
  127. AVDICOVA M, Crasta PD, Hardt K, Kovac M, et al
    Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Vaccine. 2015;33:2727-33.
    PubMed     Text format     Abstract available


    February 2015
  128. KAWANO Y, Suzuki M, Kawada JI, Kimura H, et al
    Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Vaccine. 2015 Feb 6. pii: S0264-410X(15)00132.
    PubMed     Text format     Abstract available


  129. WICHGERS SCHREUR PJ, Kant J, van Keulen L, Moormann RJ, et al
    Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Vaccine. 2015 Feb 6. pii: S0264-410X(15)00134.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: